Brief: Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement
07/11/2019 13:25
Nov 7 (Reuters) - Cellect Biotechnology Ltd APOP.O :
* CELLECT BIOTECHNOLOGY REGAINS COMPLIANCE WITH NASDAQ
MINIMUM BID
PRICE REQUIREMENT
Source text for Eikon: ID:nPn27KcW9a
Further company coverage: APOP.O
((Briefs@thomsonreuters.com;))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM